Facing a lack of patient awareness and heavy spending by big pharma competitors, our client needed a strategic plan for the launch of a genomic test able to improve cancer detection and monitoring via a blood draw. We embraced the emotional attributes of ease and confidence in marketing to the consumer using language patients clearly understood.

The brand was built on the principles of accessibility, friendliness and human connection. Digital marketing, patient communities and a globally award-winning website were developed. The brand evolved into LungLife AI and has raised $42 million in investment dollars to date.